yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q57816676-1E380D30-C5DA-4E99-B441-B84813521008
Q57816676-1E380D30-C5DA-4E99-B441-B84813521008
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57816676-1E380D30-C5DA-4E99-B441-B84813521008
The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent
P2860
Q57816676-1E380D30-C5DA-4E99-B441-B84813521008
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57816676-1E380D30-C5DA-4E99-B441-B84813521008
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1fe5c0aa4933f745c5d7c4178183ec57a2d1a3e2
P2860
Opdivo (Nivolumab): Second PD-1 Inhibitor Receives FDA Approval for Unresectable or Metastatic Melanoma